Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Thomas John C
Director at Dogwood Therapeutics · Director at ImmunityBio. Filing since 22 Nov 2016.
CIK 0001424620
DWTX
Dogwood Therapeutics, Inc.
Director · 1 trade
IBRX
ImmunityBio, Inc.
Director · 14 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DWTX
Dogwood Therapeutics, Inc.
4 Jan 2022
Director
Bought
1,000
$5.65K
opened
IBRX
ImmunityBio, Inc.
10 Dec 2020
Director
Sold, plan not stated
42,592
$461.12K
17.0%
IBRX
ImmunityBio, Inc.
19 Aug 2020
Director
Sold, plan not stated
20,000
$183.80K
7.4%
IBRX
ImmunityBio, Inc.
13 Aug 2020
Director
Sold, plan not stated
40,000
$376.60K
12.9%
IBRX
ImmunityBio, Inc.
11 Aug 2020
Director
Sold, plan not stated
20,000
$207.04K
6.1%
IBRX
ImmunityBio, Inc.
16 Dec 2019
Director
Sold, plan not stated
10,000
$31.40K
2.9%
IBRX
ImmunityBio, Inc.
13 Dec 2019
Director
Sold, plan not stated
20,000
$54.60K
5.6%
IBRX
ImmunityBio, Inc.
12 Dec 2019
Director
Sold, plan not stated
10,000
$19.92K
2.7%
IBRX
ImmunityBio, Inc.
9 Sep 2019
Director
Sold, plan not stated
13,956
$17.31K
3.6%
IBRX
ImmunityBio, Inc.
6 Sep 2019
Director
Sold, plan not stated
7,080
$8.78K
1.8%
IBRX
ImmunityBio, Inc.
5 Sep 2019
Director
Sold, plan not stated
2,964
$3.71K
0.8%
IBRX
ImmunityBio, Inc.
20 Jun 2017
Director
Sold, plan not stated
40,000
$298.50K
12.6%
IBRX
ImmunityBio, Inc.
25 Nov 2016
Director
Sold, plan not stated
6,168
$46.26K
2.0%
IBRX
ImmunityBio, Inc.
23 Nov 2016
Director
Sold, plan not stated
7,000
$52.50K
2.2%
IBRX
ImmunityBio, Inc.
22 Nov 2016
Director
Sold, plan not stated
13,000
$97.50K
3.9%
15 decisions on file.
